259 results
Page 5 of 13
8-K
EX-99.1
j6ur8n
11 Feb 21
GeoVax Announces Closing of $10.3 Million Bought Deal Offering
2:35pm
8-K
EX-99.1
3ld4ntsvv 9wm0hiwr46
11 Feb 21
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
9:21am
8-K
EX-1.01
rjpep
11 Feb 21
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
9:21am
424B5
c34ws0y nhrimhppt
11 Feb 21
Prospectus supplement for primary offering
9:17am
8-K
EX-99.1
pmq31
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-99.1
rwgyetjkl51s
5 Nov 20
GeoVax Reports 2020 Third Quarter Financial Results
5:18pm
424B3
iyij4 nu0xmeqt4
5 Nov 20
Prospectus supplement
5:17pm
8-K
EX-10.1
edukg 09m
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
8-K
EX-99.1
y78sy1
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
8-K
EX-99.1
qimar52
29 Sep 20
GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
5:24pm
424B4
0ctzr
28 Sep 20
Prospectus supplement with pricing info
4:56pm
8-K
EX-99.1
fius0pr6
25 Sep 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-1.1
1u2qrsrne902
25 Sep 20
Entry into a Material Definitive Agreement
5:25pm